HuckleB
(1000+ posts)
Send PM |
Profile |
Ignore
|
Wed Nov-18-09 12:28 PM
Original message |
|
http://www.the-scientist.com/blog/display/56151/"The government agency tasked with funding crucial life science research needs to focus more attention on ethical quandaries and nefarious business practices that often obscure the path from discovery to public benefit, says a strongly worded letter to Francis Collins, the director of the National Institutes of Health (NIH), signed by more than 100 biomedical researchers, journal editors, and health care administrators in the US.
"...we ask that you acknowledge the research gap on the effect of conflicts of interest and commercial influence on medical decision making," the letter reads, "and set in motion a process that leads to recognition of the importance of funding studies on research ethics, the beliefs and behaviors of researchers and clinicians, and the effects of industry-academic relationships on the generation and dissemination of medical knowledge."
"It would be great to raise awareness, and maybe have them actually do an RFA on this," said Adriane Fugh-Berman, director of PharmedOut, a group seeking to educate physicians on how the pharmaceutical industry influences prescribing practices, which spearheaded the writing and dissemination of the letter. PharmedOut, based at Georgetown University's School of Medicine, launched three years ago with the help of a chunk of the $430 million settlement drug maker Pfizer paid in 2004 after pleading guilty to encouraging the off-label prescription of its anti-seizure drug Neurontin.
Fugh-Berman, who is also an associate professor in Georgetown's department of physiology and biophysics, admitted that part of the impetus for the letter was the PharmedOut project's empty coffers. "We've been out of money for a year," she told The Scientist. "It's been very difficult to get money for projects."
..."------------------------------------------------------------------------------------------------------- Indeed, it should be a focus.
|